ACE insertion/deletion polymorphism and ischemic stroke susceptibility among populations from Turkey, Egypt, Iran, and Iraq: a systematic review and meta-analysis
Open Access
- 19 August 2026
- journal article
- review article
- Published by Springer Nature in The Egyptian Journal of Neurology, Psychiatry and Neurosurgery
- Vol. 62 (1) , 159
Abstract
Background: Ischemic stroke is a major cause of mortality and long-term neurological disability worldwide. Although conventional vascular risk factors explain a substantial proportion of ischemic stroke burden, genetic susceptibility may contribute to inter-individual and population-level differences in risk. The angiotensin-converting enzyme insertion/deletion (ACE I/D) polymorphism is a biologically plausible vascular candidate variant because of its relationship with ACE activity, renin-angiotensin system regulation, endothelial function, vascular remodeling, and blood-pressure control. However, findings from Middle Eastern populations remain inconsistent. Objective: To systematically evaluate and quantitatively synthesize the association between ACE I/D polymorphism and ischemic stroke susceptibility in populations from the Middle East, with inferences restricted to the countries represented in the eligible evidence—Turkey, Egypt, Iran, and Iraq. Methods: This PRISMA 2020–based systematic review and meta-analysis was prospectively registered in PROSPERO (CRD420261406483). PubMed/MEDLINE, Scopus, and Web of Science were searched from inception to May 23, 2026 for observational genetic association studies reporting ACE I/D genotype or allele data in ischemic stroke cases and stroke-free Middle Eastern controls. Two reviewers independently conducted study selection, data extraction, and Newcastle-Ottawa Scale quality assessment. Random-effects ORs with 95% CIs were pooled under allele, dominant, recessive, homozygous, and heterozygous models, with sensitivity analyses excluding studies with HWE deviation, reconstructed counts, historical controls, and other strict-quality concerns. Results: Ten studies including 1,317 ischemic stroke cases and 979 controls were included, representing Turkey, Egypt, Iran, and Iraq. Across all primary random-effects models, ACE I/D polymorphism was not significantly associated with ischemic stroke susceptibility. The pooled estimates were: allele contrast D vs. I, OR = 1.16 (95% CI: 0.97–1.38); dominant model DD + ID vs. II, OR = 1.20 (95% CI: 0.91–1.57); recessive model DD vs. ID + II, OR = 1.20 (95% CI: 0.89–1.61); homozygous model DD vs. II, OR = 1.26 (95% CI: 0.94–1.70); and heterozygous model ID vs. II, OR = 1.14 (95% CI: 0.84–1.55). Heterogeneity ranged from low to moderate across most models, with the highest heterogeneity observed in the recessive model. Sensitivity analyses, particularly the exclusion of two studies with control-group Hardy–Weinberg equilibrium deviation, consistently attenuated the pooled estimates toward the null and did not support a robust association. Conclusion: Available evidence does not demonstrate a statistically robust association between ACE I/D polymorphism and ischemic stroke susceptibility in the populations studied in Turkey, Egypt, Iran, and Iraq. Although D-allele and DD-genotype carriers showed a weak non-significant trend toward increased risk, this pattern was not stable under sensitivity analyses. Given the null pooled findings, modest evidence base, predominance of unadjusted genotype-derived estimates, and absence of reliable stroke subtype-specific data, the current evidence does not support ACE I/D genotyping for clinical ischemic stroke risk prediction. These findings should not be generalized to Middle Eastern countries for which eligible evidence was unavailable.Keywords
This publication has 27 references indexed in Scilit:
- Global, regional, and national burden of stroke and its risk factors, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021The Lancet Neurology, 2024
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviewsBMJ, 2021
- StrokeThe Lancet, 2017
- ACE Gene in Egyptian Ischemic Stroke PatientsJournal of Stroke and Cerebrovascular Diseases, 2016
- Association between the ACE I/D polymorphism and risk of ischemic stroke: An updated meta-analysis of 47,026 subjects from 105 case–control studiesJournal of the Neurological Sciences, 2014
- Angiotensin-converting enzyme insertion/deletion polymorphism has no effect on the risk of atherosclerotic stroke or hypertensionJournal of the Neurological Sciences, 2009
- Evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of ischaemic strokeJournal of Clinical Neuroscience, 2006
- Meta-analysis of Observational Studies in EpidemiologyA Proposal for ReportingJAMA, 2000
- Tissue Renin-Angiotensin System in Myocardial Hypertrophy and FailureArchives of internal medicine (1960), 1993
- Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarctionNature, 1992